ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Q32 Bio Inc

Q32 Bio Inc (QTTB)

3.34
0.07
(2.14%)
Closed 11 January 8:00AM
3.34
0.00
( 0.00% )
Pre Market: 9:43PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
3.34
Bid
3.07
Offer
3.50
Volume
296
0.00 Day's Range 0.00
2.99 52 Week Range 53.79
Previous Close
3.34
Open
-
Last Trade
27
@
3.34
Last Trade Time
21:36:54
Average Volume (3m)
368,309
Financial Volume
-
VWAP
-

QTTB Latest News

Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program

Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program PR Newswire WALTHAM, Mass., Dec. 10, 2024 -- SIGNAL-AA demonstrated encouraging...

Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update PR Newswire WALTHAM, Mass., Nov. 7, 2024 -- Bempikibart Phase 2 topline results in atopic dermatitis (AD) and...

Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference

Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference PR Newswire WALTHAM, Mass., Nov. 5, 2024 WALTHAM, Mass., Nov. 5, 2024 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB...

Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024

Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024 PR Newswire WALTHAM, Mass., Oct. 14...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.58-14.79591836733.924.14992.993709353.46871376CS
4-0.39-10.45576407513.734.14992.995289713.44825036CS
12-45.66-93.18367346944953.172.9936830910.2669433CS
26-22.83-87.237294612226.1753.792.9922413418.36214722CS
52-12.9-79.433497536916.2453.792.9916155618.95070087CS
156-12.9-79.433497536916.2453.792.9916155618.95070087CS
260-12.9-79.433497536916.2453.792.9916155618.95070087CS

QTTB - Frequently Asked Questions (FAQ)

What is the current Q32 Bio share price?
The current share price of Q32 Bio is US$ 3.34
What is the 1 year trading range for Q32 Bio share price?
Q32 Bio has traded in the range of US$ 2.99 to US$ 53.79 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
JSPRWJasper Therapeutics Inc
US$ 0.30
(87.50%)
2
ATPCAgape ATP Corporation
US$ 1.96
(55.56%)
13.38M
CELUCelularity Inc
US$ 3.17
(46.76%)
66
XHGXChange TED Inc
US$ 1.55
(37.17%)
6.77M
SAGESage Therapeutics Inc
US$ 7.60
(36.94%)
335.8k
NESRNational Energy Services Reunited Corporation
US$ 5.11
(-40.02%)
1
TCTMTCTM Kids IT Education Inc
US$ 0.4998
(-31.96%)
34.04k
CVKDCadrenal Therapeutics Inc
US$ 11.20
(-31.16%)
301
LAESSEALSQ Corporation
US$ 4.39
(-23.39%)
5.73M
LSBKLake Shore Bancorp Inc
US$ 10.31
(-23.12%)
1
GCTKGlucoTrack Inc
US$ 0.1459
(24.70%)
150.73M
RIMEAlgorhythm Holdings Inc
US$ 0.145
(7.57%)
30.36M
ATPCAgape ATP Corporation
US$ 1.96
(55.56%)
13.38M
XHGXChange TED Inc
US$ 1.55
(37.17%)
6.77M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0941
(6.81%)
6.17M

Your Recent History

Delayed Upgrade Clock